Experience of Using Talazoparib in the Aggressive Course of BRCA2-associated Triple-Negative Breast Cancer: a Clinical Observation
Meditsinskiy sovet = Medical Council(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Meditsinskiy sovet = Medical Council(2023)